FAIRFAX, Va., Sept. 18 /PRNewswire-USNewswire/ -- The American Society for Therapeutic Radiology and Oncology has welcomed two new additions to its growing staff; Barbara Muth is ASTRO's new director of research and Jennifer Frazier joins the Society as a health policy analyst.
Ms. Muth brings nearly 20 years of healthcare research experience to ASTRO. Prior to joining ASTRO, she worked with the American Red Cross for eight years as the research manager, where she was responsible for prioritizing their research agenda, working with volunteers to establish practice and training guidelines, and designing health and safety studies. She has also held positions with the Lombardi Comprehensive Cancer Center at Georgetown University in Washington and Memorial Sloan-Kettering Cancer Center in New York, managing the NCI-funded National Hispanic Leadership Initiative on Cancer Project, which was the first comprehensive assessment of cancer risk factors among the major populations of Hispanic/Latino men and women in the United States. Also at Memorial Sloan-Kettering, Ms. Muth helped to design a patient navigation program to facilitate cancer detection and treatment for low-income patients. At ASTRO, Ms. Muth will be responsible for leading ASTRO's research team in promoting research, disseminating research results, administrating ASTRO's extensive awards and grants program, and overseeing ASTRO's Research Council and the committees within it.
Ms. Frazier is the newest addition to ASTRO's Health Policy Department. She holds a Master of Public Health degree from the University of Florida at Gainesville, Fla., and before joining ASTRO, she completed a fellowship at the National Cancer Institute in health communications where she helped to plan, develop and promote cancer education programs and materials for the public, cancer patients and health professionals. She has also held a research assistant position with the University of Florida Shands Cancer Center where she worked on two studies examining the impact of cancer on the quality of life of survivors and their families. At ASTRO, Ms. Frazier will be responsible for monitoring the impact of health policy regulatory issues on radiation oncology practices, analyzing health policy regulatory proposals and providing technical assistance to members and their practice managers on practice-related issues. Ms Frazier will also serve as staff liaison to the Emerging Technology Committee and as ASTRO's staff representative to the American Medical Association's Relative Value Update committee.
"We are very excited to have Barbara and Jennifer join our staff," Laura I. Thevenot, ASTRO's chief executive officer, said. "With both of their vast experience in various cancer and public health initiatives, they will be a great asset to the Society and to our members."
ASTRO is the largest radiation oncology society in the world, with more than 9,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy.
|SOURCE American Society for Therapeutic Radiology|
Copyright©2008 PR Newswire.
All rights reserved